Express News | Certara Inc : Leerink Partners Cuts Target Price to $16 From $19
KeyBanc Maintains Certara(CERT.US) With Buy Rating, Cuts Target Price to $20
A Quick Look at Today's Ratings for Certara(CERT.US), With a Forecast Between $16 to $21
Certara Price Target Cut to $20.00/Share From $23.00 by Keybanc
Certara Is Maintained at Overweight by Keybanc
Express News | Keybanc Maintains Overweight on Certara, Lowers Price Target to $20
Express News | JMP Securities Reiterates Market Perform on Certara
BofA Securities Maintains Certara(CERT.US) With Buy Rating, Cuts Target Price to $21
Certara's Strategic Acquisition of Chemaxon: A Path to Revenue Growth and Market Expansion
Barclays Maintains Certara(CERT.US) With Hold Rating, Maintains Target Price $16
Certara (CERT) Gets a Hold From Barclays
JMP Securities Maintains Certara(CERT.US) With Hold Rating
Market Perform Rating for Certara Amid Strategic Acquisition and Mixed Financial Outlook
Certara to Acquire Chemaxon in Deal Valued at $90 Million
Express News | Certara Inc - Reiterates Full Year 2024 Guidance
Express News | Certara to Acquire Chemaxon to Strengthen Drug Discovery Software Portfolio
Is Certara (NASDAQ:CERT) A Risky Investment?
Certara to Report Second Quarter 2024 Financial Results on August 6th, 2024
Certara Is Maintained at Equal-Weight by Barclays
Barclays Lowers Price Target on Certara to $16 From $18, Maintains Equalweight Rating